Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th edn. Text Revision. Washington, DC: American Psychiatric Association, 2000
   Google Scholar
• Arnold LE. Contemporary Diagnosis and Management of ADHD, 3rd edn. Newtown, PA: Handbooks in Health Care Co, 2004
   Google Scholar
• American Academy of Pediatrics Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-70
   PubMed Web of Science ®Google Scholar
• Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005;57:1215-20
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Spencer JS. Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med 2002;53:113-31
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV. Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder. J Pediatr 1998;133:544-51
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria: I. an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990;29:546-57
   PubMed Web of Science ®Google Scholar
• Goodman DW, Ginsberg L, Weisler RH, et al. An interim analysis of the quality of life, effectiveness, safety, and tolerability (Q.U.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 2005;10(Suppl 20):26-34
   PubMedGoogle Scholar
• Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry 2006;67:524-40
   PubMed Web of Science ®Google Scholar
• Designating September 7, 2004, as ‘National Attention Deficit Disorder Day.’ Bill Number S.Res.370, 108th Congress, 2nd Session. The Library of Congress, 2004
   Google Scholar
• Prince JB. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr Clin N Am 2006;15:13-50
   PubMed Web of Science ®Google Scholar
• Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921
   PubMed Web of Science ®Google Scholar
• The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J. The stimulants. Psychiatr Clin North Am 1992;15:191-222
   PubMed Web of Science ®Google Scholar
• Pelham WE, Gnagy EM, Burrows-Maclean L, et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 2001;107:105
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237-48
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Pliszka S, Dulcan MK. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. AACAP Official Action. J Am Acad Child Adolesc Psychiatry 2002;41(Suppl):26-49S
   Google Scholar
• Daytrana [package insert]. Wayne, PA: Shire US Inc., 2008
   Google Scholar
• McGough JJ, Wigal SB, Abikoff H, et al. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord 2006;9:476-85
   PubMedGoogle Scholar
• Findling RL, Bukstein OG, Melmed RD, et al. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008;69:149-59
   PubMed Web of Science ®Google Scholar
• Bukstein OG, Vince BD, López FA, et al. Parent and teacher rated effects of MTS and OROS methylphenidate in ADHD. Poster presented at: Annual Meeting of the American Psychiatric Association. May 24, 2006; Toronto, Ontario, Canada
   Google Scholar
• Pelham WE, Burrows-MacLean L, Gnagy EM, et al. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol 2005;13:111-26
   PubMed Web of Science ®Google Scholar
• Pelham WE, Manos M, Ezzell CE, et al. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005;44:522-9
   PubMed Web of Science ®Google Scholar
• Wilens TE, Boellner SW, López FA, et al. Varying the wear time of the methyphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2008;47:700-8
   PubMed Web of Science ®Google Scholar
• Arnold LE, Lindsay RL, López FA, et al. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art. Pediatrics 2007;120:1100-6
   PubMed Web of Science ®Google Scholar
• DuPaul GJ, Power TJ, Anastopolous AD, et al. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press, 1998
   Google Scholar
• Clinical global impressions. In: Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised. DHEW Pub. No. ADM 76-338. Rockville, MD: US Dept of Health, Education and Welfare, 1976:218-22
   Google Scholar
• Connors CK. Connors’ Rating Scales – Revised: Technical Manual. New York, NY: Multi-Health Systems Inc., 1997
   Google Scholar
• Rapport MD, Moffitt C. Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects. Clin Psychol Rev 2002;22:1107-31
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Pelham WE Jr, López FA, et al. Once-daily transdermal methylphenidate improves teacher, parent, and CGI-I ratings. Poster presented at: 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 22-27, 2002; San Francisco, CA
   Google Scholar
• Data on File. Study File N17-021. Shire Development Inc., Wayne, PA, USA
   Google Scholar